Latest News

Date Title Topic
27 Sep 2015 ESMO @ ECC 2015: Blocking PD1 Shows Promise in Merkel Cell Carcinoma Melanoma - Immuno-oncology
27 Sep 2015 ESMO @ ECC 2015: Novel Atezolizumab Shows Promise in Metastatic Urothelial Carcinoma Genitourinary cancers - Immuno-oncology
27 Sep 2015 ESMO @ ECC 2015: Novel Assay Developed to Determine PD-L2 Expression in Tumour Samples Pathology/Molecular biology - Immuno-oncology
27 Sep 2015 ESMO Commentary: Atezolizumab Set to Change Refractory Lung Cancer Treatment Lung and other thoracic tumours - Immuno-oncology
26 Sep 2015 ESMO Commentary: Migrants, Refugees and Neglected Patient Populations: nationality and social status still affect cancer care quality Bioethics, legal and economic issues
26 Sep 2015 ESMO @ ECC 2015: Cabozantinib Out-Performs Everolimus in Advanced Renal Cell Carcinoma Genitourinary cancers - Anticancer agents & Biologic therapy
26 Sep 2015 ESMO @ ECC 2015: Regional Hyperthermia Added to Neoadjuvant Chemotherapy Doubles Length of Overall Survival in Patients With Localised High-Risk Soft Tissue Sarcoma Sarcomas - Anticancer agents & Biologic therapy
26 Sep 2015 ESMO @ ECC 2015: TURANDOT: First-Line Bevacizumab Plus Capecitabine Shows Non-Inferior Overall Survival versus Bevacizumab plus Paclitaxel for Metastatic Breast Cancer Breast cancer - Anticancer agents & Biologic therapy
26 Sep 2015 ESMO @ ECC 2015: Anti-tumour Activity Demonstrated with Orteronel in Metastatic Castration Resistant Prostate Cancer Genitourinary cancers - Anticancer agents & Biologic therapy
26 Sep 2015 ESMO Young Oncologists Contribute to Medscape Live Blog from ECC 2015
26 Sep 2015 ESMO Press Release: Six New Countries Join the List of ESMO Designated Centres of Integrated Oncology and Palliative Care Palliative and supportive care
Abstracts
23 Sep 2015 Press Release: ESMO Announces Christoph Zielinski as Editor-in-Chief 
of New Open Access Journal
21 Sep 2015 Nearly 800 Abstracts Submitted to ESMO Asia 2015
21 Sep 2015 ESMO 2016 – Abstract Submission and Programme